The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

Jan. 17, 2019
Applicants:

Miltenyi Biotec B.v. & Co. KG, Gladbach, DE;

Charite-universitätsmedizin Berlin, Berlin, DE;

Inventors:

Anna Nowak, Berlin, DE;

Dominik Lock, Cologne, DE;

Andrew Kaiser, Rösrath, DE;

Alexander Scheffold, Berlin, DE;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/725 (2006.01); A61K 35/12 (2015.01); A61K 39/00 (2006.01); C07K 14/705 (2006.01); C07K 16/44 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 39/4611 (2023.05); A61K 39/4621 (2023.05); A61K 39/4631 (2023.05); A61K 39/464 (2023.05); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 14/70521 (2013.01); C07K 14/70578 (2013.01); C07K 16/44 (2013.01); C12N 5/0637 (2013.01); A61K 2035/122 (2013.01); A61K 2239/22 (2023.05); C07K 2317/622 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01);
Abstract

The present invention provides a regulatory T (Treg) cell expressing an antigen chimeric receptor (CAR) comprising a) at least one antigen binding domain, b) a transmembrane domain, and c) a cytoplasmic signaling domain comprising at least one primary cytoplasmic signaling domain and at least the co-stimulatory signaling domain of CD137, wherein said antigen binding domain specifically binds an antigen that is expressed on the surface of a target cell or a tag of a tagged polypeptide that binds to an antigen expressed on the surface of a target cell or a soluble antigen. Compositions comprising said Treg cells, and methods of enrichment and analysis of activated Tregs that express said CAR are also disclosed.


Find Patent Forward Citations

Loading…